RT Journal Article
SR Electronic
T1 Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007929
DO 10.1136/jitc-2023-007929
VO 12
IS 1
A1 Makker, Vicky
A1 Taylor, Matthew H
A1 Aghajanian, Carol
A1 Cohn, Allen L
A1 Brose, Marcia S
A1 Simone, Christopher Di
A1 Cao, Zhu Alexander
A1 Suttner, Leah
A1 Loboda, Andrey
A1 Cristescu, Razvan
A1 Jelinic, Petar
A1 Orlowski, Robert
A1 Dutta, Lea
A1 Matsui, Junji
A1 Dutcus, Corina E
A1 Minoshima, Yukinori
A1 Messing, Mark J
YR 2024
UL http://jitc.bmj.com/content/12/1/e007929.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.